06/18/2025
4:12 PM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2025
7:24 PM | Spero Therapeutics (Issuer)
THOMAS FRANK E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
7:24 PM | Smith Cynthia (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
7:26 PM | Pottage John C Jr (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
7:28 PM | Spero Therapeutics (Issuer)
VINK PATRICK V.J.J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
7:29 PM | Jackson Scott Thomas (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
7:30 PM | Deshpande Milind (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
7:32 PM | Mahadevia Ankit (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
7:24 PM | Spero Therapeutics (Issuer)
Tregoning Kathleen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2025
6:12 AM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2025
7:01 PM | Rajavelu Esther (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for SPRO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Spero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/28/2025
4:08 PM | Spero Therapeutics (Filer)
| Form ARS | |
04/28/2025
3:29 PM | Spero Therapeutics (Filer)
| Form DEFA14A | |
03/28/2025
3:30 PM | GSK plc (Filed by)
Spero Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
03/27/2025
4:19 PM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2025
3:30 PM | Spero Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2025
4:11 PM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
8:04 PM | Keutzer Timothy (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
7:52 PM | Rajavelu Esther (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
7:30 PM | Mahadevia Ankit (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
7:31 PM | Shukla Sath (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
6:00 AM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:37 PM | Anson Funds Management LP (Filed by)
Spero Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
3:02 PM | Spero Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2024
4:01 PM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
5:56 AM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
5:36 PM | Shukla Sath (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
5:42 PM | Keutzer Timothy (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
5:43 PM | Mahadevia Ankit (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
6:56 PM | Shukla Sath (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
